U.S. markets open in 7 hours 2 minutes
  • S&P Futures

    4,413.00
    -2.00 (-0.05%)
     
  • Dow Futures

    34,976.00
    -22.00 (-0.06%)
     
  • Nasdaq Futures

    15,063.50
    +17.25 (+0.11%)
     
  • Russell 2000 Futures

    2,215.00
    -4.40 (-0.20%)
     
  • Crude Oil

    70.50
    -0.06 (-0.09%)
     
  • Gold

    1,815.80
    +1.70 (+0.09%)
     
  • Silver

    25.73
    +0.15 (+0.58%)
     
  • EUR/USD

    1.1876
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    1.1760
    0.0000 (0.00%)
     
  • Vix

    18.04
    -1.42 (-7.30%)
     
  • GBP/USD

    1.3927
    +0.0012 (+0.09%)
     
  • USD/JPY

    109.1100
    +0.0600 (+0.06%)
     
  • BTC-USD

    37,911.65
    -495.74 (-1.29%)
     
  • CMC Crypto 200

    926.90
    -16.54 (-1.75%)
     
  • FTSE 100

    7,105.72
    +24.00 (+0.34%)
     
  • Nikkei 225

    27,584.08
    -57.75 (-0.21%)
     

Why Checkpoint Therapeutics Skyrocketed Today

·1 min read
Why Checkpoint Therapeutics Skyrocketed Today

One very big stock market winner on Wednesday was Checkpoint Therapeutics (NASDAQ: CKPT). B. Riley Securities prognosticator Justin Walsh is bullish on Checkpoint. Walsh is so hot on Checkpoint's prospects, he's initiating his coverage with a buy rating and an $18 per-share price target -- which was nearly seven times Tuesday's closing stock price.